AstraZeneca & Isis Pharmaceuticals Collaborate For New Antisense Drugs To Treat Renal Diseases
News
Isis Pharmaceuticals, Inc. and AstraZeneca have recently announced they are strategically collaborating to advance antisense therapies to address metabolic, cardiovascular and renal diseases. This new collaboration is based on an already existing relationship between the two ... Read more